<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">120495</article-id><article-id pub-id-type="doi">10.23868/gc120495</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Morphofunctional reaction of T-lymphoblasts of Jurkat line on the titanium oxides coating</article-title><trans-title-group xml:lang="ru"><trans-title>Морфофункциональная реакция Т-лимфобластов линии Jurkat на покрытие из оксидов титана</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khlusov</surname><given-names>I. A</given-names></name><name xml:lang="ru"><surname>Хлусов</surname><given-names>И. А</given-names></name></name-alternatives><email>khlusov63@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Litvinova</surname><given-names>L. S</given-names></name><name xml:lang="ru"><surname>Литвинова</surname><given-names>Л. С</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shupletsova</surname><given-names>V. V</given-names></name><name xml:lang="ru"><surname>Шуплецова</surname><given-names>В. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sokhonevich</surname><given-names>N. A</given-names></name><name xml:lang="ru"><surname>Сохоневич</surname><given-names>Н. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khaziakhmatova</surname><given-names>O. G</given-names></name><name xml:lang="ru"><surname>Хазиахматова</surname><given-names>О. Г</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khlusova</surname><given-names>M. Yu</given-names></name><name xml:lang="ru"><surname>Хлусова</surname><given-names>М. Ю</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sharkeev</surname><given-names>Yu. P</given-names></name><name xml:lang="ru"><surname>Шаркеев</surname><given-names>Ю. П</given-names></name></name-alternatives><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pichugin</surname><given-names>V. F</given-names></name><name xml:lang="ru"><surname>Пичугин</surname><given-names>В. Ф</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Siberian State Medical University</institution></aff><aff><institution xml:lang="ru">Сибирский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Tomsk Polytechnic University</institution></aff><aff><institution xml:lang="ru">Томский политехнический университет</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">I. Kant Baltic Federal University</institution></aff><aff><institution xml:lang="ru">Балтийский федеральный университет им. И. Канта</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Institute of Strength Physics and Materials Science of SB RAS</institution></aff><aff><institution xml:lang="ru">Институт физики прочности и материаловедения СО РАН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2015</year></pub-date><volume>10</volume><issue>1</issue><issue-title xml:lang="en">VOL 10, NO1 (2015)</issue-title><issue-title xml:lang="ru">ТОМ 10, №1 (2015)</issue-title><fpage>83</fpage><lpage>90</lpage><history><date date-type="received" iso-8601-date="2023-01-05"><day>05</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Эко-Вектор</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/120495">https://genescells.ru/2313-1829/article/view/120495</self-uri><abstract xml:lang="en"><p>Human leukemic T-lymphoblastoid cells (hereinafter Jurkat T-cells) which was applied actively for modeling of T-lymphocytes reaction have been used in vitro We have examined morphofunctional response of Jurkat T-cells to 24-h in vitro contact with titanium substrates (12x12x1 mm3) covered by titanium oxide (TiO, TiO2) bilateral coating that was prepared by microarc method from an aqueous solution of 20 mass % orthophosphoric acid. 27-98% of immortalized cells in control culture (without an addition of the specimens) had CD3+CD4+CD71+CD45RA+ immunophenotype and secreted IL-2, IL-4, IL-8, IL-10 and TNFα, but not IL-1b and IL-6. Other markers of cell activation, differentiation, maturation and death (CD8, CD16, CD56, CD25, CD95) were found at 0 - 2. 5% of the cell population. The addition of bulk specimens with oxide coating reduced statistically CD3, CD4, CD8 и CD95 membrane markers presentation on Jurkat T-cells and decreased IL-4 and TNFα secretion Structural (antigens expression) and functional (cytokines secretion) Jurkat T-cells inactivation was not connected with the generation of intracellular reactive oxygen species (ROS), and was not mediated by TiO2 nanoparticles (diameter of 14±8 nm; doses of 1 mg/L or 10 mg/L) which can be released under samples biodegradation. Spearman's correlation analysis showed the inhibiting action of the oxide surface roughness in the range of Ra = 2,2-3,7 μm on the number of viable Jurkat T-cells (rs = -0. 95; n = 9; p&lt;0. 0001) due to an elevating portion of necrotic forms in the cellular population, mainly In turn, magnitude of negative electrostatic potential of the oxide surface rose linearly (r = 0. 6; p&lt;0. 000001, n = 60) with increase in the Ra roughness index The roughness of the oxide coating induces its surface voltage that seems to promote morphofunctional suppression of tumor immune cells by electrostatic/biological mechanisms are not connected with intracellular ROS generation</p></abstract><trans-abstract xml:lang="ru"><p>В исследовании in vitro были использованы лейкозные Т-лимфобластоподобные клетки человека (далее Jurkat Т-клетки), активно применяемые для моделирования in vitro реакций Т-лимфоцитов Изучена морфофункциональная реакция Jurkat Т-клеток на 24-часовой контакт с титановыми подложками (12x12x1 мм3), несущими двустороннее покрытие из оксидов титана (TiO, TiO2), сформированное микродуговым методом в водном растворе 20% ортофосфорной кислоты. 27-98% иммортализированных клеток в контрольной культуре (без добавления образцов) имели CD3+/CD4+/CD71+/CD45RA+ иммунофенотип и секретировали IL-2, IL-4, IL-8, IL-10 и TNFa, но не IL-1b и IL-6. Другие маркеры клеточной активации, дифференцировки, созревания и смерти (CD8, CD16, CD56, CD25, CD95) обнаруживались у 0-2,5% клеточной популяции Добавление объемных образцов с оксидным покрытием статистически значимо снижало на Jurkat Т-клетках презентацию мембранных маркеров CD3,CD4,CD8 и CD95, уменьшало секрецию IL-4 и TNFa. Структурная (уменьшение экспрессии антигенов) и функциональная (снижение секреции цитокинов) инактивация Jurkat Т-клеток не была связана с генерацией внутриклеточных активных форм кислорода (АФК), не опосредовалась TiO2 наночастицами (диаметр 14±8 нм; доза 1 мг/л или 10 мг/л), которые способны высвобождаться при биодеградации образцов Корреляционный анализ по Спирмену показал ингибирующее действие шероховатости оксидной поверхности в интервале Ra = 2,2-3,7 мкм на число жизнеспособных Jurkat Т-клеток (rs = -0,95; n = 9; p&lt;0,0001), преимущественно, за счет увеличения в клеточной популяции доли некротических форм В свою очередь, с увеличением индекса шероховатости Ra линейно возрастала (r = 0,6; p&lt;0,000001, n = 60) амплитуда отрицательного электростатического потенциала оксидной поверхности Шероховатость оксидного покрытия индуцирует его поверхностный потенциал, который, предположительно, способствует морфофункциональной супрессии опухолевых иммунокомпетентных клеток через электростатические/ биологические механизмы, не связанные с генерацией внутриклеточных АФК.</p></trans-abstract><kwd-group xml:lang="en"><kwd>in vitro</kwd><kwd>membrane markers</kwd><kwd>cytokines</kwd><kwd>reactive oxygen species</kwd><kwd>apoptosis</kwd><kwd>necrosis</kwd><kwd>in vitro</kwd><kwd>titanium substrates</kwd><kwd>TiO nanoparticles</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>мембранные маркеры</kwd><kwd>цитокины</kwd><kwd>активные формы кислорода</kwd><kwd>апоптоз</kwd><kwd>некроз</kwd><kwd>титановые подложки</kwd><kwd>TiO наночастицы</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>ГОСТ Р ИСО 10993-20-2009 Изделия медицинские. Оценка биологического действия медицинских изделий. Часть 20. Принципы и методы исследования иммунотоксичности медицинских изделий. Введ. 2010-09-01. М.: Стандартинформ; 2010.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Au A. , Ha J., Hernandez M. et al. Nickel and Vanadium Metal Ions Induce Apoptosis of T-lymphocyte Jurkat cells J Biomed Mater Res. A. 2006; 79(3): 512-21.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Chen X. , Su J. , Chang J. et al. Inhibition of cD147 Gene Expression via RNA Interference Reduces Tumor cell Proliferation, Activation, Adhesion, and Migration Activity in the Human Jurkat T-lymphoma cell Line. cancer Invest. 2008; 26(7): 689-97.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Stevens M. J., Donato L. J., Lower S. K. et al. Oxide-dependent Adhesion of the Jurkat Line of T lymphocytes. Langmuir. 2009; 25t11): 6270-8</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Caicedo M. , Jacobs J. J. , Reddy A. et al. Analysis of Metal Ioninduced DNA Damage, Apoptosis, and Necrosis in Human (Jurkat) T-cells Demonstrates Ni2+ and V3+ are more Toxic than other Metals: Al3 + , Be2 + , co2 + , cr3 + , cu2 + , Fe3 + , Mo5 + , Nb5 + , Zr2 +. J. Biomed. Mater. Res. A. 2008; 86t4): 905-13.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Tuomela S., Autio R., Buerki-Thurnherr T. et al. Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles. PLoS One 2013; 8(7): e68415.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Хлусов И.А., Сурменева М. A., Сурменев Р. А. и др. Клеточно-молекулярные аспекты иммунологической совместимости имплантатов с наноструктурным кальцийфосфатным покрытием. Бюллетень сибирской медицины 2012; 4: 78-85.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Ratner B. D. , Hoffman A. S., Schoen F.J. et al., editors. Biomaterials Science: an introduction to materials in medicine. 2nd ed. San Diego: Elsevier Academic Press; 2004.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Thull R. Titan in der Zahnheilkunde-Grundlagen. Z. Mitteilungen. 1992; 82: 39-45.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Ogawa T. Ultraviolet photofunctionalization of titanium implants. Int. J. Oral Maxillofac. Implants 2014; 29(1): e95-102.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Curtis A. S., Varde M. Control of cell behavior: topological factors. J. Natl. Cancer Inst. 1964; 33: 15-26.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Legostaeva E.V., Kulyashova K. S., Komarova E. G. et al. Physical, chemical and biological properties of micro-arc deposited calcium phosphate coatings on titanium and zirconium-niobium alloy. Mat. -wiss. u.Werkstofftech. 2013; 44(2-3): 188-97.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Гостищев Э. А., Сурменев Р. А., Хлусов И. А. и др. Исследование биоэлектрической совместимости тонких кальций-фосфатных покрытий, полученных методом высокочастотного магнетронного распыления. Известия Томского политехнического университета 2011; 319(2): 108-13.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Де Вита В. Т. , Хеллман С., Розенберг С.А., редакторы. Биологические методы лечения онкологических заболеваний: Пер. с англ М: Медицина; 2002</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Gallagher P. F. , Fazekas de St Groth B. , Miller J. F. CD4 and CD8 molecules can physically associate with the same T-cell receptor PNAS USA 1989; 86: 10044-8.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Law H. K. W. , Tu W. , Liu E. et al. Insulin-like growth factor I promotes cord blood T cell maturation through monocytes and inhibits their apoptosis in part through interleukin-6 BMC Immunology 2008; 9: 74-86. doi:10. 1186/1471-2172-9-74.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Bi B.Y., Lefebvre A. M., Dus D. et al. Effect of lactoferrin on proliferation and differentiation of the Jurkat human lymphoblastic T cell line. Arch. Immunol. Ther. Exp (Warsz). 1997; 45(4): 315-20.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Akbar A. N., Terry L., Timms A. et al. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J. Immun. 1988; 140: 2171-78.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Khalaf H , Jass J , Olsson P E Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-Cells. BMC Immunol. 2010; 27: 11-26.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Waugh D. J. J. , Wilson C. The interleukin-8 pathway in cancer Clin. Cancer Res. 2008; 14(21): 6735-41.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Arana-Argaez V. E. , Delgado-Rizo V. , Pizano-Martinez O. E. et al. Inhibitors of MAPK pathway ERK1/2 or p38 prevent the IL-1-induced up-regulation of SRP72 autoantigen in Jurkat cells J Biol Chem. 2010; 285: 32824-33.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Tatsuta T., Cheng J., Mountz J. D. Intracellular IL-1beta is an inhibitor of fas-mediated apoptosis. J. Immunol. 1996; 157(9): 3949-57.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Groux H., Bigler M., de Vries J. E. et al. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T Cells. J. Exp. Med. 1996; 184: 19-29.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Montet-Abou K., Montet X., Weissleder R. et al. Transfection agent induced nanoparticle cell loading. Mol. Imaging 2005; 4(3): 165-71.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Stevens M. J. , Donato L. J. , Lower S. K. et al. Oxide-dependent adhesion of the Jurkat line of T lymphocytes. Langmuir. 2009; 25(11): 6270-8</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Khlusov I. A. , Khlusova M. Y. , Pichugin V. F. et al. Artificial niches for stromal stem cells as a potential instrument for the design of the surface of biomimetic osteogenic materials Russian Phys J 2014; 56(10): 1206-11.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Самойлов В. О. Медицинская биофизика. СПб: СпецЛит; 2007.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Sundelacruz S. , Levin M. , Kaplan D. L. Role of membrane potential in the regulation of cell proliferation and differentiation. Stem Cell Rev. 2009; 5: 231-46.</mixed-citation></ref></ref-list></back></article>
